Table II.
Comparison of MMP-2 expression and clinicopathological characteristics of glioma.
| MMP-2 expression | ||||||
|---|---|---|---|---|---|---|
| Item | Groups | n (104) | Positive (n=76) | Negative (n=28) | χ2 | P-value |
| Sex | 0.84 | 0.115 | ||||
| Male | 58 | 42 | 16 | |||
| Female | 46 | 34 | 12 | |||
| Age (years) | 1.14 | 0.097 | ||||
| <30 years | 15 | 11 | 4 | |||
| 30–50 years | 35 | 26 | 9 | |||
| >50 years | 54 | 39 | 15 | |||
| Tumor diameter | 5.72 | 0.017 | ||||
| <3 cm | 31 | 16 | 15 | |||
| >3 cm | 73 | 60 | 13 | |||
| Tumor location | 1.61 | 0.063 | ||||
| Frontal lobe | 18 | 13 | 5 | |||
| Temporal lobe | 43 | 32 | 11 | |||
| Parietal lobe | 35 | 25 | 10 | |||
| Others | 8 | 6 | 2 | |||
| Pathological type | 1.53 | 0.058 | ||||
| Astrocytoma | 54 | 38 | 16 | |||
| Oligodendroglioma | 44 | 33 | 11 | |||
| Others | 6 | 5 | 1 | |||
| Pathological grade | 6.28 | 0.023 | ||||
| I–II | 23 | 13 | 10 | |||
| III | 48 | 34 | 14 | |||
| IV | 33 | 29 | 4 | |||
MMP-2, matrix metalloproteinase-2.